Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 12/16/2025China Approves Genzyme's Fenthosilan Sodium Injection
  • 12/16/2025InnoCare's Orelabrutinib Hits Primary Endpoint in Phase 2b Lupus Trial...
  • 12/15/2025Qilu Advances GSPT1 Degrader ADC Program, PCT Patent Reveals
  • 12/15/2025AusperBio Reports Promising Phase 2a Results for AHB-137 in Chronic He...
  • 12/15/2025Qilu Wins Approval for China's First Fully Human Anti-EGFR Antibody
  • 12/15/2025InnoCare Secures NMPA Approval for Pan-TRK Inhibitor Zurletrectinib
  • 12/12/2025CMS's NDA for Innovative Stroke Drug Y-3 for Injection Accepted in Ch...
  • 12/12/2025Ascletis' Acne Drug Denifanstat Enters NMPA Review After NDA Acceptanc...
  • 12/12/2025InnoCare Pharma Wins NMPA Approval for Next-Gen TRK Inhibitor Zurletre...
  • 12/11/2025China Approves Sanofi's Qfitlia (fitusiran) for Severe Hemophilia
  • 12/11/2025Forward Pharma Reports Promising Early Data for Oral SERD FWD1802
  • 12/11/2025Hengrui Launches Phase 1/2 Trial of Subcutaneous PD-1/VEGF BsAb SHR-46...
  • 12/11/2025Kelingyuan Reports Early Tumor Responses for Novel HER2-Targeted ADC S...
  • 12/11/2025China Approves Boehringer Ingelheim's Jascayd for Progressive Pulmonar...
  • 12/10/2025Dizal Showcases Broad ASH25 Data for Golidocitinib and Birelentinib
  • 12/10/2025InnoCare Highlights Strong ASH25 Data for BCL2 Inhibitor Mesutoclax
  • 12/10/2025Lepu Reports Encouraging Phase II Results for CD20-Targeted ADC Combo
  • 12/9/2025Ascletis Reports Positive Phase II Results for Oral GLP-1 Agonist ASC3...
  • 12/9/2025Biokin Reports Strong Phase 2 Results for HER2-Targeted ADC T-Bren
  • 12/8/2025Pfizer Files for Approval of Zavegepant Nasal Spray in China
  • 12/8/2025CSPC's Semaglutide Injection Moves Forward — sNDA Accepted, Obesity I...
  • 12/4/2025Lynk Receives FDA IND Approval for Its Brain-Penetrant Allosteric TYK2...
  • 12/1/2025New ADC Shows Broad Antitumor Activity With Strong Bystander Effect
  • 12/1/2025Innovent's Pecondle Wins China Approval as First Homegrown IL-23p19 An...
  • 11/28/2025Gan & Lee Launches GRADUAL-3 Phase 3 Trial of Once-Monthly Bofanglutid...
  • 11/28/2025Zhongmou Reports Strong First-in-Human Results for Optogenetic Gene Th...
  • 11/28/2025BeOne Secures USFDA Priority Review for Sonrotoclax
  • 11/27/2025Novartis's Rhapsido Approved for Chronic Spontaneous Urticaria in Chin...
  • 11/27/2025Ascentage Pharma Publishes Phase Ib Data for Olverembatinib in GIST
  • 11/27/2025NMPA Approves AstraZeneca's Imfinzi for NSCLC in China
  • Page:1/20 Total number of articles:597: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group